PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
BACKGROUND: Fibromyalgia (FM) is a chronic musculoskeletal pain condition characterized by sensory hypersensitivity, widespread pain and fatigue. AIMS: To evaluate the effects of NovoTHOR® whole-body PBM on fibromyalgia. METHOD: Forty-Two patients in a triple-blind, placebo-controlled trial were randomized to receive active or placebo NovoTHOR whole-body PBM, three times a week for four weeks. RESULTS: There were statistically significant differences in pain and quality of life in favour of the active treatment group at the end of 4-weeks. CONCLUSION: NovoTHOR whole-body PBM significantly reduces pain and improves quality of life in patients with fibromyalgia.
James D. Carroll
"Whole-body photobiomodulation treatment of fibromyalgia: a triple-blinded randomized clinical trial", Proc. SPIE PC12362, Mechanisms of Photobiomodulation Therapy XVII, PC1236207 (17 March 2023); https://doi.org/10.1117/12.2656889
ACCESS THE FULL ARTICLE
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
James D. Carroll, "Whole-body photobiomodulation treatment of fibromyalgia: a triple-blinded randomized clinical trial," Proc. SPIE PC12362, Mechanisms of Photobiomodulation Therapy XVII, PC1236207 (17 March 2023); https://doi.org/10.1117/12.2656889